T-KNIFE THERAPEUTICS

T-knife Therapeutics is a biopharmaceutical company dedicated to developing novel therapeutics to fight cancer... We are focused on T cell receptor engineered T cell therapies, TCR-Ts, a promising modality that holds the potential to generate transformational responses in patients with solid tumors. By armoring T cells with the most advanced enhancements in a single T cell, T-knife is designing T cell therapies to achieve a clinically meaningful impact for patients... Through the use of natural, fully human TCRs and tailored armoring, T-knife's product candidates are designed to induce an organically optimized immune signaling cascade intended to stimulate a potent T cell-driven immune response. Our TCR therapies target tumor antigens in multiple, difficult to treat solid tumor indications.

Also known as: T-knife, T-knife GmbH, T-knife Therapeutics, Inc.

VAT numbers: DE302400807

Primary location: Berlin Germany